Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Sonosine logo — Deep-tech firm set to dramatically improve clinical decision...

Sonosine

Deep-tech firm set to dramatically improve clinical decision making with an advanced world-class medical imaging device

Founded 2015 United Kingdom United Kingdom 7 employees Seed Biotechnology, Health Care +1

General Information

Company Name Sonosine
Founded Year 2015
Location United Kingdom United Kingdom +1
Employees 7
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Seed
Social

Get notified when Sonosine moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Sonosine

Sonosine is a deep-tech startup that aims to revolutionize clinical decision making with its innovative medical imaging device, the Pulsar 1. Established in 2015 and based in the United Kingdom, Sonosine's mission is to improve healthcare worldwide, including in underserved communities and less developed countries. The company's team comprises experts from various sectors, including business, industry, and academia, and they are dedicated to introducing unprecedented technology to medical specialists, ultimately enhancing patient care. The Pulsar 1 utilizes patented Electro Magnetic Acoustic (EMA) imaging technology, offering swift, safe, and comfortable medical diagnostics for patients while providing clinicians with reliable images for optimal decision making. As a spin-out from the University of Oxford, Sonosine is committed to leveraging its profound technical and industrial knowledge to transform how clinicians diagnose and treat patients in primary care settings. By doing so, the Pulsar 1 will effectively eliminate the need for medical imaging center referrals and invasive, costly procedures. Although specific investment details are not currently available, Sonosine's innovative approach and potential impact on the healthcare industry make it an intriguing prospect for venture capitalists.

No funding data available for Sonosine yet.

Get notified when Sonosine raises funding

Sonosine Alternatives & Competitors

Sonosine vs
Lucid Medical Diagnostics
Lucid Medical Diagnostics India

Most preferred, one-stop destination for all common to complex pathology tests.

91 employees
Biotechnology, Health Care
Sonosine vs
OCCYO
OCCYO Austria

Intelligent Ocular Imaging

13 employees
Health Care, Manufacturing
Sonosine vs
Optellum
Optellum United Kingdom

Early lung cancer diagnosis with AI

Series A
49 employees
Health Care, Medical Devices

FAQ About Sonosine

Deep-tech firm set to dramatically improve clinical decision making with an advanced world-class medical imaging device
Sonosine was founded in 2015.
Sonosine is headquartered in United Kingdom.
Sonosine operates in the following industries: Biotechnology, Health Care, Medical Devices.
Sonosine has approximately 7 employees.
Top alternatives and competitors to Sonosine include Lucid Medical Diagnostics, OCCYO, Optellum, ProScan Imaging, Ocumetra. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sonosine and Lucid Medical Diagnostics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Sonosine and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy